Brainsway Ltd Market Cap ($394.54 Million)
Market Cap & Net Worth: Brainsway Ltd (BWAY)
Brainsway Ltd market cap. Brainsway Ltd (TA:BWAY) has a market capitalization of $394.54 Million (ILA147.16 Billion) as of November 1, 2026. Listed on the TA stock exchange, this Israel-based company holds position #13128 globally and #140 in its home market, demonstrating a -2.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brainsway Ltd's stock price ILA3656.00 by its total outstanding shares 40252989 (40.25 Million). Also see Brainsway Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Brainsway Ltd Market Cap History (2015–2026)
Brainsway Ltd market cap history from 2015 to 2026. Data shows growth from $251.99 Million to $394.54 Million (3.67% CAGR). Check Brainsway Ltd (BWAY) share price today for real-time trading data and today's change.
Brainsway Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brainsway Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Brainsway Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
5.97x
Brainsway Ltd's market cap is 5.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
40.82x
Brainsway Ltd's market cap is 40.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $174.39 Million | $11.52 Million | -$2.40 Million | 15.13x | N/A |
| 2017 | $180.76 Million | $11.14 Million | -$7.05 Million | 16.22x | N/A |
| 2018 | $231.91 Million | $16.40 Million | -$6.48 Million | 14.14x | N/A |
| 2019 | $180.76 Million | $23.10 Million | -$10.33 Million | 7.82x | N/A |
| 2020 | $123.03 Million | $22.06 Million | -$5.38 Million | 5.58x | N/A |
| 2021 | $129.72 Million | $29.66 Million | -$6.46 Million | 4.37x | N/A |
| 2022 | $38.38 Million | $27.18 Million | -$13.35 Million | 1.41x | N/A |
| 2023 | $124.10 Million | $31.79 Million | -$4.20 Million | 3.90x | N/A |
| 2024 | $187.88 Million | $41.02 Million | $2.92 Million | 4.58x | 64.32x |
| 2025 | $337.24 Million | $56.53 Million | $8.26 Million | 5.97x | 40.82x |
Competitor Companies of BWAY by Market Capitalization
Companies near Brainsway Ltd in the global market cap rankings as of November 1, 2026. Also see Brainsway Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Brainsway Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Brainsway Ltd (2015–2026)
Market capitalization of Brainsway Ltd from 2015 to today. Between 2015 and today, Brainsway Ltd's market cap moved from $251.99 Million to $ 394.54 Million, with a yearly change of 3.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA394.54 Million | +16.99% |
| 2025 | ILA337.24 Million | +79.49% |
| 2024 | ILA187.88 Million | +51.39% |
| 2023 | ILA124.10 Million | +223.40% |
| 2022 | ILA38.38 Million | -70.42% |
| 2021 | ILA129.72 Million | +5.44% |
| 2020 | ILA123.03 Million | -31.94% |
| 2019 | ILA180.76 Million | -22.06% |
| 2018 | ILA231.91 Million | +28.30% |
| 2017 | ILA180.76 Million | +3.65% |
| 2016 | ILA174.39 Million | -30.79% |
| 2015 | ILA251.99 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Brainsway Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $394.54 Million USD |
| MoneyControl | $394.54 Million USD |
| MarketWatch | $394.54 Million USD |
| marketcap.company | $394.54 Million USD |
| Reuters | $394.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more